Access to the archived section is available to free members. Please log in to your free member account to view this content. If you don’t have an account yet, you can create one for free to gain access.

Grants and In-Kind Support to USA, Canada, and UK Researchers to Encourage the Development of Drugs to Prevent, Treat, and Reverse Alzheimer's Disease

GrantWatch ID# 182103
Agency: Foundation
Geographic Focus
USA: AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew York CityNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashington, DCWashingtonWest VirginiaWisconsinWyoming
USA Territories: American Samoa (USA);   Guam (USA);   Puerto Rico (USA);   Virgin Islands (USA);   Northern Mariana Islands (USA);
Canada: Alberta;   British Columbia;   Manitoba;   New Brunswick;   Newfoundland and Labrador;   Northwest Territories;   Nova Scotia;   Nunavut;   Ontario;   Prince Edward Island;   Quebec;   Saskatchewan;   Yukon;
Important Dates
LOI Date: 06/02/25
Deadline: 08/18/25 5:00 PM EDT
Short Grant Description

Grants and in-kind assistance and advice to USA, Canada, and UK faculty members at IHEs or research centers to promote the development of drugs to prevent, treat, reverse, or slow the development of Alzheimer's disease and related dementias. Applicants must submit a le...

View Full Grant Details